BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 38385061)

  • 1. A review on trends in development and translation of omics signatures in cancer.
    Ma W; Tang W; Kwok JSL; Tong AHY; Lo CWS; Chu ATW; Chung BHY;
    Comput Struct Biotechnol J; 2024 Dec; 23():954-971. PubMed ID: 38385061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome.
    Boufraqech M; Nilubol N
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31835496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
    Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
    Front Immunol; 2021; 12():687975. PubMed ID: 34276676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onco-Multi-OMICS Approach: A New Frontier in Cancer Research.
    Chakraborty S; Hosen MI; Ahmed M; Shekhar HU
    Biomed Res Int; 2018; 2018():9836256. PubMed ID: 30402498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning in the identification of prognostic DNA methylation biomarkers among patients with cancer: A systematic review of epigenome-wide studies.
    Yuan T; Edelmann D; Fan Z; Alwers E; Kather JN; Brenner H; Hoffmeister M
    Artif Intell Med; 2023 Sep; 143():102589. PubMed ID: 37673571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment.
    Díaz-Gay M; Vangara R; Barnes M; Wang X; Islam SMA; Vermes I; Duke S; Narasimman NB; Yang T; Jiang Z; Moody S; Senkin S; Brennan P; Stratton MR; Alexandrov LB
    Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38096571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy.
    Xing X; Hu E; Ouyang J; Zhong X; Wang F; Liu K; Cai L; Zhou Y; Wang Y; Chen G; Li Z; Wu L; Liu X
    Cell Rep Med; 2023 Dec; 4(12):101315. PubMed ID: 38091986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.
    Prosz A; Duan H; Tisza V; Sahgal P; Topka S; Klus GT; Börcsök J; Sztupinszki Z; Hanlon T; Diossy M; Vizkeleti L; Stormoen DR; Csabai I; Pappot H; Vijai J; Offit K; Ried T; Sethi N; Mouw KW; Spisak S; Pathania S; Szallasi Z
    Sci Rep; 2023 Nov; 13(1):20567. PubMed ID: 37996508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation.
    Mälarstig A; Grassmann F; Dahl L; Dimitriou M; McLeod D; Gabrielson M; Smith-Byrne K; Thomas CE; Huang TH; Forsberg SKG; Eriksson P; Ulfstedt M; Johansson M; Sokolov AV; Schiöth HB; Hall P; Schwenk JM; Czene K; Hedman ÅK
    Nat Commun; 2023 Nov; 14(1):7680. PubMed ID: 37996402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma.
    Wang J; Sun N; Kunzke T; Shen J; Zens P; Prade VM; Feuchtinger A; Berezowska S; Walch A
    NPJ Precis Oncol; 2023 Nov; 7(1):114. PubMed ID: 37919427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic structural variation signatures in pediatric brain tumors.
    Yang Y; Yang L
    Cell Rep; 2023 Oct; 42(10):113276. PubMed ID: 37851574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale plasma proteomics comparisons through genetics and disease associations.
    Eldjarn GH; Ferkingstad E; Lund SH; Helgason H; Magnusson OT; Gunnarsdottir K; Olafsdottir TA; Halldorsson BV; Olason PI; Zink F; Gudjonsson SA; Sveinbjornsson G; Magnusson MI; Helgason A; Oddsson A; Halldorsson GH; Magnusson MK; Saevarsdottir S; Eiriksdottir T; Masson G; Stefansson H; Jonsdottir I; Holm H; Rafnar T; Melsted P; Saemundsdottir J; Norddahl GL; Thorleifsson G; Ulfarsson MO; Gudbjartsson DF; Thorsteinsdottir U; Sulem P; Stefansson K
    Nature; 2023 Oct; 622(7982):348-358. PubMed ID: 37794188
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.